Press Releases genOway OTC Markets

Equities

GWYNF

FR0004053510

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2023	GenOway: sharp rise, broker initiates buy recommendation	CF
2023	GENOWAY : Euroland initiates buy coverage	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GenOway : Résultats annuels 2023	Mar. 27	PU
GenOway : Résultats du 1er semestre 2023	23-09-22	PU
GenOway: Proposal of a new administrator	22-05-23	PU
GenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology	22-01-25	PR
GenOway : and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models	20-01-07	AQ
GenOway : The Institut Pasteur and Cellectis extend exclusive license rights by granting genOway the authority to take action against infringement	19-11-04	PU
Genoway : Conventional KO (constitutive)	16-07-26	PU
GENOWAY : A grant for €1.9 million has been awarded under the Eurostars™ programme to a consortium that comprises Abzena, Antitope, Prothix BV, Aristi Biotech BV, the University Medical Center Utrecht, and genOway	16-01-28	PU
GENOWAY : The 11th ISTT Prize will be jointly awarded to Jennifer Doudna and Emmanuelle Charpentier at the TT2016 meeting.	15-04-23	PU
GENOWAY : Genetically Modified Models by CRISPR/Cas9 Nuclease System	14-09-08	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer